Druggable	Report_C1	Report_C2	Tumor_VAF	Normal_VAF	DP_T	DP_N	SF_TVAF	SF_TDP	CHROM	Start	End	REF	ALT	FILTER	Gene	Transcript	Exon/Intron_Number	cHGVS	pHGVS	Type_Annotation	CLNSIG	CLNCONF	CLNDN	MPOS	POSD
1	NRAS(0.1%)	exon4,c.437C>T,p.A146V	0.0008977	0.001213	8570|8	3007|4	0.00131	35858|47	1	115252203	115252203	G	A	clustered_events,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.437C>T	p.Ala146Val	missense_variant				51	0.0
1	NRAS(0.0%)	exon4,c.436G>T,p.A146S	0.0002854	0.0006992	8561|6	2992|2	0.00192	35871|69	1	115252204	115252204	C	A	base_qual,clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.436G>T	p.Ala146Ser	missense_variant				39	0.0
1	NRAS(0.0%)	exon4,c.436G>C,p.A146P	0.0001633	0.0004302	8561|3	2992|4	0.00200	35871|72	1	115252204	115252204	C	G	base_qual,clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.436G>C	p.Ala146Pro	missense_variant				48	0.0
1	NRAS(0.0%)	exon4,c.436G>A,p.A146T	0.0002147	0.0006713	8561|3	2992|2	0.00120	35871|43	1	115252204	115252204	C	T	base_qual,clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.436G>A	p.Ala146Thr	missense_variant				59	0.0
1	NRAS(0.1%)	exon3,c.183A>T,p.Q61H	0.0005157	0.0005526	5025|5	2242|5	0.00204	20038|41	1	115256528	115256528	T	A	base_qual,clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	3	c.183A>T	p.Gln61His	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|_Uncertain_significance(1)	Hepatocellular_carcinoma|Acute_myeloid_leukemia|Melanoma|Adrenocortical_carcinoma|B-cell_chronic_lymphocytic_leukemia|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Adenocarcinoma_of_stomach|Neoplasm_of_the_thyroid_gland|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Ovarian_Serous_Cystadenocarcinoma|Glioblastoma|Noonan_syndrome_and_Noonan-related_syndrome|Malignant_neoplasm_of_body_of_uterus|not_provided	18	0.0
1	NRAS(0.0%)	exon3,c.181C>G,p.Q61E	0.000366	0.0005485	4980|4	2228|1	0.00080	19870|16	1	115256530	115256530	G	C	base_qual,clustered_events,strand_bias,weak_evidence	NRAS	NM_002524.5	3	c.181C>G	p.Gln61Glu	missense_variant	Pathogenic		Melanoma	61	0.0
1	NRAS(0.1%)	exon3,c.176C>A,p.A59D	0.0009291	0.0005754	4707|5	2105|2	0.00198	18670|37	1	115256535	115256535	G	T	clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	3	c.176C>A	p.Ala59Asp	missense_variant	Likely_pathogenic		Anemia|Noonan_syndrome	41	0.0
1	NRAS(0.1%)	exon3,c.175G>T,p.A59S	0.0005868	0.0005763	4689|3	2098|0	0.00151	18550|28	1	115256536	115256536	C	A	clustered_events,strand_bias,weak_evidence	NRAS	NM_002524.5	3	c.175G>T	p.Ala59Ser	missense_variant				40	0.0
1	NRAS(0.1%)	exon3,c.175G>A,p.A59T	0.0007996	0.0006167	4689|4	2098|1	0.00065	18550|12	1	115256536	115256536	C	T	clustered_events,strand_bias,weak_evidence	NRAS	NM_002524.5	3	c.175G>A	p.Ala59Thr	missense_variant	Likely_pathogenic		not_provided	24	0.0
1	NRAS(0.0%)	exon2,c.38G>T,p.G13V	0.0003351	0.0003562	9993|7	3746|1	0.00162	43105|70	1	115258744	115258745	C	A	clustered_events,normal_artifact,weak_evidence	NRAS	NM_002524.5	2	c.38G>T	p.Gly13Val	missense_variant	Pathogenic/Likely_pathogenic		Acute_myeloid_leukemia|Neoplasm|Melanoma|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Malignant_melanoma_of_skin|Non-Hodgkin_lymphoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Myelodysplastic_syndrome	20	0.0
1	NRAS(0.0%)	exon2,c.38G>C,p.G13A	0.000299	0.0003555	9993|4	3746|0	0.00123	43105|53	1	115258744	115258745	C	G	clustered_events,normal_artifact,weak_evidence	NRAS	NM_002524.5	2	c.38G>C	p.Gly13Ala	missense_variant	Pathogenic		Melanoma	12	0.0
1	NRAS(0.1%)	exon2,c.38G>A,p.G13D	0.001148	0.0009707	9993|11	3746|3	0.00070	43105|30	1	115258744	115258745	C	T	clustered_events,normal_artifact,weak_evidence	NRAS	NM_002524.5	2	c.38G>A	p.Gly13Asp	missense_variant	Pathogenic/Likely_pathogenic		Acute_myeloid_leukemia|Melanoma|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Malignant_melanoma_of_skin|Juvenile_myelomonocytic_leukemia|Non-Hodgkin_lymphoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Noonan_syndrome_6|RAS-associated_autoimmune_leukoproliferative_disorder|Myelodysplastic_syndrome|Acute_megakaryoblastic_leukemia_in_down_syndrome|not_provided	41	0.0
1	NRAS(0.0%)	exon2,c.37G>T,p.G13C	0.0001994	0.0003655	10014|3	3739|3	0.00308	43400|134	1	115258745	115258745	C	A	clustered_events,strand_bias,weak_evidence	NRAS	NM_002524.5	2	c.37G>T	p.Gly13Cys	missense_variant	Pathogenic		Melanoma	31	0.0
1	NRAS(0.0%)	exon2,c.37G>A,p.G13S	0.0004852	0.000359	10014|6	3739|2	0.00044	43400|19	1	115258745	115258745	C	T	clustered_events,strand_bias,weak_evidence	NRAS	NM_002524.5	2	c.37G>A	p.Gly13Ser	missense_variant	Likely_pathogenic		Neoplasm_of_stomach	50	0.0
1	NRAS(0.1%)	exon2,c.34G>A,p.G12S	0.0005245	0.0003588	9887|8	3679|0	0.00094	42716|40	1	115258748	115258748	C	T	clustered_events,strand_bias,weak_evidence	NRAS	NM_002524.5	2	c.34G>A	p.Gly12Ser	missense_variant	Pathogenic		Acute_myeloid_leukemia|Melanoma|Multiple_myeloma|Malignant_melanoma_of_skin|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Noonan_syndrome_6|Myelodysplastic_syndrome|Noonan_syndrome|Noonan_syndrome_and_Noonan-related_syndrome|Rasopathy|Malignant_neoplasm_of_body_of_uterus|not_provided	30	0.0
	SPTA1(28.7%)	exon40,c.5572C>G,p.L1858V	0.287	0.145	53|19	6|0	0.24390	62|20	1	158597507	158597507	G	C	germline,Germline	SPTA1	NM_003126.4	40	c.5572C>G	p.Leu1858Val	missense_variant	Benign/Likely_benign		Hemolytic_anemia|Pyropoikilocytosis|Elliptocytosis_2|Spherocytosis_type_3|not_specified|not_provided	46	0.0
	SPTA1(42.6%)	exon37,c.5292C>A,p.A1764=	0.426	0.155	16|12	4|0	0.43333	17|13	1	158606449	158606449	G	T	germline,Germline	SPTA1	NM_003126.4	37	c.5292C>A	p.Ala1764=	synonymous_variant	Benign		Pyropoikilocytosis|Elliptocytosis_2|Spherocytosis_type_3|not_specified|not_provided	41	0.0
	H3-3A(4.2%)	exon4,c.344C>G,p.A115G	0.042	0.024	338|12	51|0	0.06786	467|34	1	226259113	226259113	C	G	contamination,strand_bias,background	H3-3A	NM_002107.7	4	c.344C>G	p.Ala115Gly	missense_variant				58	0.0
	DNMT3A(47.1%)	exon2,c.27C>T,p.P9=	0.471	0.169	16|13	4|0	0.54545	15|18	2	25536827	25536827	G	A	germline	DNMT3A	NM_022552.5	2	c.27C>T	p.Pro9=	synonymous_variant	Benign		Tatton-Brown-rahman_syndrome|not_provided	40	0.0
	SRBD1(0.1%)	exon10,c.1395G>A,p.W465*	0.001257	0.0007887	9759|15	4019|3	0.00137	45315|62	2	45789806	45789806	C	T	low_allele_frac	SRBD1	NM_018079.5	10	c.1395G>A	p.Trp465*	stop_gained				53	0.0
-	MSH2(5.4%)	exon2,c.212-5_212-4del	0.054	0.088	317|30	40|7	0.03704	806|31	2	47635523	47635525	CTT	C	multiallelic,normal_artifact	MSH2	NM_000251.3	1	c.212-5_212-4del		splice_region_variant&intron_variant				50	0.0
-	MSH2(14.5%)	exon2,c.212-4del	0.145	0.166	317|85	40|13	0.17503	806|171	2	47635523	47635525	CTT	CT	multiallelic,normal_artifact,suspected_bg	MSH2	NM_000251.3	1	c.212-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Lynch_syndrome_I|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	49	0.0
-	MSH2(10.6%)	exon2,c.212-4dup	0.106	0.088	317|64	40|9	0.14799	806|140	2	47635523	47635525	CTT	CTTT	multiallelic,normal_artifact,suspected_bg	MSH2	NM_000251.3	1	c.212-4dup		splice_region_variant&intron_variant	Benign		Lynch_syndrome_I|Hereditary_cancer-predisposing_syndrome|not_specified|Breast_and/or_ovarian_cancer	43	0.0
-	MSH2(2.2%)	exon2,c.212-5_212-4dup	0.022	0.053	317|13	40|3	0.02774	806|23	2	47635523	47635525	CTT	CTTTT	multiallelic,normal_artifact	MSH2	NM_000251.3	1	c.212-5_212-4dup		splice_region_variant&intron_variant				33	0.0
-	MSH2(1.8%)	exon2,c.212-4T>A	0.018	0.014	584|16	85|0	0.02867	1355|40	2	47635536	47635536	T	A	weak_evidence,background	MSH2	NM_000251.3	1	c.212-4T>A		splice_region_variant&intron_variant	Likely_benign		Hereditary_nonpolyposis_colorectal_neoplasms	48	0.0
-	MSH6(6.5%)	exon5,c.3261del,p.F1088fs	0.065	0.058	4806|400	983|66	0.05999	14211|907	2	48030639	48030640	AC	A	normal_artifact,slippage,suspected_bg	MSH6	NM_000179.3	5	c.3261del	p.Phe1088fs	frameshift_variant	Pathogenic		Lynch-like_syndrome|Endometrial_carcinoma|Carcinoma_of_colon|Lynch_syndrome|Hereditary_nonpolyposis_colorectal_cancer_type_5|Hereditary_cancer-predisposing_syndrome|Mismatch_repair_cancer_syndrome_3|Hereditary_nonpolyposis_colorectal_neoplasms|not_provided	40	0.0
-	MSH6(30.7%)	exon7,c.3557-4del	0.307	0.162	19|9	6|0	0.37838	23|14	2	48032740	48032741	AT	A	germline,slippage,suspected_bg	MSH6	NM_000179.3	6	c.3557-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_nonpolyposis_colorectal_cancer_type_5|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	31	0.0
	BMPR2(0.6%)	exon12,c.1748del,p.N583fs	0.005978	0.011	5970|51	1858|26	0.00883	17408|155	2	203420129	203420130	GA	G	normal_artifact,suspected_bg,low_allele_frac	BMPR2	NM_001204.7	12	c.1748del	p.Asn583fs	frameshift_variant	Pathogenic		Pulmonary_arterial_hypertension|Primary_pulmonary_hypertension|Idiopathic_and/or_familial_pulmonary_arterial_hypertension	36	0.0
1	IDH1(0.0%)	exon4,c.395G>T,p.R132L	0.0004691	0.00197	5745|6	1804|4	0.00512	19634|101	2	209113112	209113112	C	A	base_qual,clustered_events,orientation,weak_evidence	IDH1	NM_005896.4	4	c.395G>T	p.Arg132Leu	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Breast_neoplasm|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Adenocarcinoma_of_prostate|Glioblastoma|Myelodysplastic_syndrome	50	0.0
1	IDH1(0.1%)	exon4,c.394C>T,p.R132C	0.001365	0.001934	5739|9	1807|2	0.00289	18603|54	2	209113113	209113113	G	A	clustered_events,normal_artifact,weak_evidence	IDH1	NM_005896.4	4	c.394C>T	p.Arg132Cys	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Astrocytoma|Breast_neoplasm|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Adenocarcinoma_of_prostate|Glioblastoma|Myelodysplastic_syndrome|not_provided	38	0.0
	UGT1A1(1.2%)	exon,c.-55_-54insAT	0.012	0.011	5948|120	2516|62	0.01867	34587|658	2	234668879	234668883	CATAT	CATATAT	clustered_events,multiallelic,normal_artifact,suspected_bg	UGT1A1	NM_000463.3		c.-55_-54insAT		upstream_gene_variant	Conflicting_interpretations_of_pathogenicity|_drug_response|_other	Pathogenic(5)|_Benign(4)	Gilbert_syndrome|Lucey-Driscoll_syndrome|Crigler-Najjar_syndrome,_type_II|Crigler-Najjar_syndrome_type_1|Bilirubin,_serum_level_of,_quantitative_trait_locus_1|Irinotecan_response|not_specified|not_provided	47	0.0
2	FANCD2(7.4%)	exon6,c.378-5del	0.074	0.067	677|74	123|10	0.08246	1135|102	3	10076842	10076843	CT	C	multiallelic,normal_artifact,slippage,background	FANCD2	NM_033084.6	5	c.378-5del		splice_region_variant&intron_variant				46	0.0
2	FANCD2(5.2%)	exon6,c.378-5dup	0.052	0.034	677|50	123|4	0.07043	1135|86	3	10076842	10076843	CT	CTT	multiallelic,normal_artifact,slippage,suspected_bg	FANCD2	NM_033084.6	5	c.378-5dup		splice_region_variant&intron_variant				43	0.0
	TGFBR2(10.6%)	exon4,c.458del,p.K153fs	0.106	0.092	840|107	139|14	0.09325	1517|156	3	30691871	30691872	GA	G	normal_artifact,slippage,suspected_bg	TGFBR2	NM_001024847.2	4	c.458del	p.Lys153fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1)|_Benign(3)|_Likely_benign(1)	Loeys-Dietz_syndrome|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_specified|Cardiovascular_phenotype|not_provided	39	0.0
	ANO10(6.1%)	exon2,c.132del,p.D45fs	0.061	0.06	4939|354	1412|98	0.05890	16011|1002	3	43647212	43647213	CT	C	haplotype,normal_artifact,slippage,suspected_bg	ANO10	NM_018075.5	2	c.132del	p.Asp45fs	frameshift_variant	Pathogenic		not_provided	45	0.0
	ATR(9.7%)	exon10,c.2320del,p.I774fs	0.097	0.075	5147|648	1645|166	0.07447	17114|1377	3	142274739	142274740	AT	A	multiallelic,normal_artifact,slippage,background	ATR	NM_001184.4	10	c.2320del	p.Ile774fs	frameshift_variant	Pathogenic		Endometrial_neoplasm|not_provided	41	0.0
	ATR(1.5%)	exon10,c.2320dup,p.I774fs	0.015	0.016	5147|133	1645|47	0.03300	17114|584	3	142274739	142274740	AT	ATT	multiallelic,normal_artifact,slippage,suspected_bg	ATR	NM_001184.4	10	c.2320dup	p.Ile774fs	frameshift_variant	Pathogenic		not_provided	46	0.0
1	PIK3CA(0.1%)	exon10,c.1624G>A,p.E542K	0.001249	0.0009318	5186|6	1766|1	0.00108	15655|17	3	178936082	178936082	G	A	clustered_events,orientation,strand_bias,weak_evidence,background	PIK3CA	NM_006218.4	10	c.1624G>A	p.Glu542Lys	missense_variant	Pathogenic		CEREBRAL_CAVERNOUS_MALFORMATIONS_4,_SOMATIC|Cerebrofacial_Vascular_Metameric_Syndrome_(CVMS)|Hepatocellular_carcinoma|Abnormality_of_cardiovascular_system_morphology|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Carcinoma_of_esophagus|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Adenocarcinoma_of_prostate|Squamous_cell_carcinoma_of_the_head_and_neck|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Capillary_malformation_of_the_lower_lip,_lymphatic_malformation_of_face_and_neck,_asymmetry_of_face_and_limbs,_and_partial/generalized_overgrowth|Glioblastoma|Lip_and_oral_cavity_carcinoma|Overgrowth_syndrome_and/or_cerebral_malformations_due_to_abnormalities_in_MTOR_pathway_genes|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus|not_provided	45	0.0
1	PIK3CA(0.1%)	exon10,c.1633G>A,p.E545K	0.00129	0.0007638	5134|6	1725|0	0.00078	15277|12	3	178936091	178936092	G	A	clustered_events,orientation,weak_evidence	PIK3CA	NM_006218.4	10	c.1633G>A	p.Glu545Lys	missense_variant	Pathogenic/Likely_pathogenic		Cerebrofacial_Vascular_Metameric_Syndrome_(CVMS)|Segmental_undergrowth_associated_with_lymphatic_malformation|Hepatocellular_carcinoma|Abnormality_of_cardiovascular_system_morphology|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Neoplasm_of_stomach|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Seborrheic_keratosis|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Sarcoma|Neoplasm_of_ovary|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Carcinoma_of_gallbladder|Breast_adenocarcinoma|Adenocarcinoma_of_prostate|Gallbladder_cancer|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Megalencephaly-capillary_malformation-polymicrogyria_syndrome|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus|Eccrine_Angiomatous_Hamartoma|OVARIAN_CANCER,_EPITHELIAL,_SOMATIC|PIK3CA_related_overgrowth_spectrum|not_provided	46	0.0
1	PIK3CA(0.0%)	exon10,c.1633G>C,p.E545Q	0.000274	0.0007698	5134|3	1725|3	0.00111	15277|17	3	178936091	178936092	G	C	clustered_events,orientation,weak_evidence	PIK3CA	NM_006218.4	10	c.1633G>C	p.Glu545Gln	missense_variant	Pathogenic/Likely_pathogenic|_drug_response		Histone_Methylation_Therapy_response|Hepatocellular_carcinoma|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Carcinoma_of_gallbladder|Adenocarcinoma_of_prostate|Head_and_Neck_Neoplasms|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus	47	0.0
1	PIK3CA(0.0%)	exon10,c.1634A>C,p.E545A	0.0002769	0.0007709	5103|6	1719|3	0.00207	15391|32	3	178936092	178936092	A	C	clustered_events,orientation,strand_bias,weak_evidence	PIK3CA	NM_006218.4	10	c.1634A>C	p.Glu545Ala	missense_variant	Pathogenic		Hepatocellular_carcinoma|Abnormality_of_cardiovascular_system_morphology|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Carcinoma_of_gallbladder|Adenocarcinoma_of_prostate|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus	55	0.0
1	PIK3CA(0.1%)	exon10,c.1634A>G,p.E545G	0.0007701	0.0007649	5103|4	1719|0	0.00097	15391|15	3	178936092	178936092	A	G	clustered_events,orientation,strand_bias,weak_evidence	PIK3CA	NM_006218.4	10	c.1634A>G	p.Glu545Gly	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Melanoma|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Brainstem_glioma|Epidermal_nevus|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Carcinoma_of_gallbladder|Adenocarcinoma_of_prostate|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus	51	0.0
1	PIK3CA(0.0%)	exon10,c.1634A>T,p.E545V	0.0002762	0.0007649	5103|4	1719|1	0.00227	15391|35	3	178936092	178936092	A	T	clustered_events,orientation,strand_bias,weak_evidence	PIK3CA	NM_006218.4	10	c.1634A>T	p.Glu545Val	missense_variant	Pathogenic		Breast_neoplasm|Neoplasm_of_the_large_intestine	55	0.0
1	PIK3CA(0.0%)	exon10,c.1635G>C,p.E545D	0.0002784	0.0007805	5124|3	1720|2	0.00123	15421|19	3	178936093	178936093	G	C	base_qual,clustered_events,strand_bias,weak_evidence	PIK3CA	NM_006218.4	10	c.1635G>C	p.Glu545Asp	missense_variant	Likely_pathogenic		Breast_neoplasm	36	0.0
1	PIK3CA(0.1%)	exon21,c.3139C>T,p.H1047Y	0.0007352	0.0004578	7411|6	2838|0	0.00047	32209|15	3	178952084	178952085	C	T	clustered_events,orientation,weak_evidence	PIK3CA	NM_006218.4	21	c.3139C>T	p.His1047Tyr	missense_variant	Pathogenic		Segmental_undergrowth_associated_with_mainly_venous_malformation_with_capillary_component|Hepatocellular_carcinoma|Medulloblastoma|Adrenocortical_carcinoma|Congenital_macrodactylia|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Neoplasm_of_stomach|Breast_neoplasm|Brainstem_glioma|Epidermal_nevus|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Seborrheic_keratosis|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Adenocarcinoma_of_prostate|Lung_carcinoma|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Megalencephaly-capillary_malformation-polymicrogyria_syndrome|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Capillary_malformation_of_the_lower_lip,_lymphatic_malformation_of_face_and_neck,_asymmetry_of_face_and_limbs,_and_partial/generalized_overgrowth|Cowden_syndrome_5|Cowden_syndrome|Familial_cancer_of_breast|Glioblastoma|Malignant_tumor_of_floor_of_mouth|Malignant_neoplasm_of_body_of_uterus|not_provided	55	0.0
	FGFR3(2.0%)	exon15,c.2002_2008delinsTACGTTT,p.D668_V670>YVF	0.02	0.011	380|5	104|0	0.01942	606|12	4	1808026	1808032	GACCGAG	TACGTTT	clustered_events,contamination,haplotype,strand_bias,suspected_bg	FGFR3	NM_000142.5	15	c.2002_2008delinsTACGTTT	p.Asp668_Val670delinsTyrValPhe	missense_variant				27	0.0
1	PDGFRA(0.0%)	exon18,c.2525A>T,p.D842V	0.0002859	0.0007872	9608|5	2396|5	0.00222	29682|66	4	55152093	55152093	A	T	base_qual,orientation,strand_bias,weak_evidence	PDGFRA	NM_006206.6	18	c.2525A>T	p.Asp842Val	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(2)|_Uncertain_significance(1)	Gastrointestinal_stroma_tumor|not_provided	21	0.0
1	KIT(0.1%)	exon11,c.1669T>A,p.W557R	0.0006236	0.000396	9653|14	3226|5	0.00429	39688|171	4	55593603	55593603	T	A	base_qual,clustered_events,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1669T>A	p.Trp557Arg	missense_variant	Pathogenic/Likely_pathogenic		Melanoma|Gastrointestinal_stroma_tumor	52	0.0
	KIT(0.0%)	exon11,c.1669T>G,p.W557G	0.0001451	0.0003941	9653|6	3226|2	0.00138	39688|55	4	55593603	55593603	T	G	base_qual,clustered_events,strand_bias,weak_evidence,low_allele_frac	KIT	NM_000222.3	11	c.1669T>G	p.Trp557Gly	missense_variant	Likely_pathogenic		Gastrointestinal_stroma_tumor	35	0.0
1	KIT(0.0%)	exon11,c.1676T>A,p.V559D	0.0003344	0.0004319	9656|11	3184|14	0.00486	39296|192	4	55593610	55593610	T	A	base_qual,clustered_events,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1676T>A	p.Val559Asp	missense_variant	Pathogenic/Likely_pathogenic		Melanoma|Gastrointestinal_stroma_tumor	44	0.0
1	KIT(0.0%)	exon11,c.1676T>C,p.V559A	0.0003153	0.0004002	9656|5	3184|0	0.00084	39296|33	4	55593610	55593610	T	C	base_qual,clustered_events,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1676T>C	p.Val559Ala	missense_variant	Pathogenic/Likely_pathogenic		Melanoma|Thymoma|Gastrointestinal_stroma_tumor|Cutaneous_mastocytosis|Gastrointestinal_stromal_tumor,_familial	43	0.0
1	KIT(0.0%)	exon11,c.1676T>G,p.V559G	0.0001493	0.0004656	9656|20	3184|18	0.00650	39296|257	4	55593610	55593610	T	G	base_qual,clustered_events,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1676T>G	p.Val559Gly	missense_variant	Pathogenic/Likely_pathogenic		Melanoma|Gastrointestinal_stroma_tumor	35	0.0
1	KIT(0.0%)	exon11,c.1727T>C,p.L576P	0.00043	0.0008807	9159|5	2816|1	0.00040	35073|14	4	55593661	55593661	T	C	clustered_events,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1727T>C	p.Leu576Pro	missense_variant	Likely_pathogenic		Melanoma|Non-small_cell_lung_carcinoma|Thymoma|Gastrointestinal_stroma_tumor	22	0.0
1	KIT(0.0%)	exon13,c.1924A>G,p.K642E	0.0002092	0.0005152	8633|3	2504|0	0.00043	30115|13	4	55594221	55594221	A	G	base_qual,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	13	c.1924A>G	p.Lys642Glu	missense_variant	Pathogenic		Melanoma|Hematologic_neoplasm|Malignant_melanoma_of_skin|Adenocarcinoma_of_stomach|Gastrointestinal_stroma_tumor|Gastrointestinal_stromal_tumor,_familial	56	0.0
1	KIT(0.1%)	exon14,c.2009C>T,p.T670I	0.0006925	0.002201	5623|3	1214|2	0.00069	13106|9	4	55595519	55595519	C	T	contamination,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	14	c.2009C>T	p.Thr670Ile	missense_variant	Likely_pathogenic		Gastrointestinal_stroma_tumor	36	0.0
1	KIT(0.0%)	exon17,c.2459A>T,p.D820V	0.0003335	0.0005118	9939|4	2789|3	0.00223	44211|99	4	55599333	55599333	A	T	base_qual,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	17	c.2459A>T	p.Asp820Val	missense_variant	Likely_pathogenic		Systemic_mast_cell_disease	19	0.0
1	KIT(0.0%)	exon17,c.2460T>G,p.D820E	0.0001493	0.0005309	9952|3	2788|4	0.00090	44171|40	4	55599334	55599334	T	G	base_qual,strand_bias,weak_evidence	KIT	NM_000222.3	17	c.2460T>G	p.Asp820Glu	missense_variant	Pathogenic		Thymoma	47	0.0
-	FBXW7(22.4%)	exon6,c.585-5del	0.224	0.445	11|5	1|2	0.25000	51|17	4	153268227	153268228	CA	C	contamination,germline,multiallelic,suspected_bg	FBXW7	NM_001349798.2	5	c.585-5del		splice_region_variant&intron_variant				20	0.0
-	FBXW7(13.6%)	exon6,c.585-4G>T	0.136	0.125	11|4	1|0	0.25000	51|17	4	153268227	153268228	C	A	contamination,germline,multiallelic,background	FBXW7	NM_001349798.2	5	c.585-4G>T		splice_region_variant&intron_variant				22	0.0
-	FBXW7(18.6%)	exon6,c.585-5dup	0.186	0.141	11|3	1|0	0.07273	51|4	4	153268227	153268228	CA	CAA	contamination,germline,multiallelic,distinguished	FBXW7	NM_001349798.2	5	c.585-5dup		splice_region_variant&intron_variant				48	0.0
	FAT1(33.2%)	exon17,c.10310C>T,p.A3437V	0.332	0.007746	1434|725	342|1	0.33366	2025|1014	4	187527264	187527264	G	A	PASS	FAT1	NM_005245.4	17	c.10310C>T	p.Ala3437Val	missense_variant				35	0.0
	SDHA(0.1%)	exon6,c.629G>A,p.R210Q	0.001432	0.001356	10677|16	2802|2	0.00178	35847|64	5	228307	228307	G	A	strand_bias,low_allele_frac	SDHA	NM_004168.4	6	c.629G>A	p.Arg210Gln	missense_variant	Uncertain_significance		Paragangliomas_5|Hereditary_cancer-predisposing_syndrome|Mitochondrial_complex_II_deficiency,_nuclear_type_1	40	0.0
	MSH3(1.4%)	exon7,c.1148del,p.K383fs	0.014	0.013	4921|89	1924|34	0.01958	16022|320	5	79970914	79970915	CA	C	clustered_events,multiallelic,normal_artifact,slippage,suspected_bg	MSH3	NM_002439.5	7	c.1148del	p.Lys383fs	frameshift_variant	Pathogenic		Endometrial_carcinoma|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_4|not_provided	37	0.0
	MSH3(2.5%)	exon7,c.1148dup,p.N385fs	0.025	0.021	4921|142	1924|57	0.02631	16022|433	5	79970914	79970915	CA	CAA	clustered_events,multiallelic,normal_artifact,slippage,suspected_bg	MSH3	NM_002439.5	7	c.1148dup	p.Asn385fs	frameshift_variant	Pathogenic		not_provided	40	0.0
-	APC(18.9%)	exon5,c.423-4del	0.189	0.355	233|69	45|27	0.17553	465|99	5	112111309	112111310	TA	T	germline,multiallelic,normal_artifact,suspected_bg	APC	NM_000038.6	4	c.423-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Malignant_Colorectal_Neoplasm|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_1|not_specified|not_provided	36	0.0
-	APC(9.1%)	exon5,c.423-4dup	0.091	0.095	233|41	45|7	0.12594	465|67	5	112111309	112111310	TA	TAA	germline,multiallelic,normal_artifact,suspected_bg	APC	NM_000038.6	4	c.423-4dup		splice_region_variant&intron_variant	Benign		Familial_adenomatous_polyposis_1|not_specified	39	0.0
	RAD50(0.3%)	exon13,c.2164_2165del,p.K722fs	0.003173	0.003009	4782|23	1729|6	0.00290	19628|57	5	131931451	131931453	TAA	T	multiallelic,normal_artifact,low_allele_frac	RAD50	NM_005732.4	13	c.2164_2165del	p.Lys722fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome	47	0.0
	RAD50(6.4%)	exon13,c.2165del,p.K722fs	0.064	0.06	4782|385	1729|132	0.06203	19628|1298	5	131931451	131931453	TAA	TA	multiallelic,normal_artifact,suspected_bg	RAD50	NM_005732.4	13	c.2165del	p.Lys722fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome	45	0.0
	RAD50(2.2%)	exon13,c.2165dup,p.E723fs	0.022	0.026	4782|144	1729|68	0.03134	19628|635	5	131931451	131931453	TAA	TAAA	multiallelic,normal_artifact,suspected_bg	RAD50	NM_005732.4	13	c.2165dup	p.Glu723fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided	40	0.0
	CYP21A2(5.1%)	exon1,c.29_31del,p.L10del	0.051	0.024	214|11	45|0	0.05294	322|18	6	32006214	32006217	CCTG	C	contamination,slippage,suspected_bg	CYP21A2	NM_000500.9	1	c.29_31del	p.Leu10del	disruptive_inframe_deletion	Benign		not_specified|not_provided	48	0.0
	ROS1(0.3%)	exon39,c.6216G>A,p.R2072=	0.003206	0.004097	2229|7	329|0	0.00188	4253|8	6	117632200	117632200	C	T	background,low_allele_frac	ROS1	NM_002944.3	39	c.6216G>A	p.Arg2072=	synonymous_variant				45	0.0
1	EGFR(0.1%)	exon18,c.2125G>A,p.E709K	0.0007189	0.0009348	5417|3	1380|0	0.00104	14367|15	7	55241677	55241677	G	A	clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	18	c.2125G>A	p.Glu709Lys	missense_variant	drug_response		Tyrosine_kinase_inhibitor_response	49	0.0
1	EGFR(0.0%)	exon18,c.2125G>C,p.E709Q	0.0002794	0.0009346	5417|5	1380|0	0.00201	14367|29	7	55241677	55241677	G	C	clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	18	c.2125G>C	p.Glu709Gln	missense_variant				46	0.0
1	EGFR(0.1%)	exon18,c.2126A>T,p.E709V	0.000598	0.001889	5365|9	1372|3	0.00329	14245|47	7	55241678	55241678	A	T	base_qual,clustered_events,weak_evidence	EGFR	NM_005228.5	18	c.2126A>T	p.Glu709Val	missense_variant	Uncertain_significance		not_specified	29	0.0
1	EGFR(0.0%)	exon18,c.2153T>A,p.L718Q	0.000342	0.001199	3988|3	1033|0	0.00254	10205|26	7	55241705	55241705	T	A	clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	18	c.2153T>A	p.Leu718Gln	missense_variant				28	0.0
1	EGFR(0.1%)	exon18,c.2156G>A,p.G719D	0.0008103	0.002435	3829|4	987|2	0.00061	9765|6	7	55241708	55241708	G	A	clustered_events,normal_artifact,weak_evidence	EGFR	NM_005228.5	18	c.2156G>A	p.Gly719Asp	missense_variant	Likely_pathogenic		Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Glioblastoma	24	0.0
1	EGFR(0.1%)	exon18,c.2170G>A,p.G724S	0.00134	0.001327	3287|4	891|0	0.00050	7969|4	7	55241722	55241722	G	A	clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	18	c.2170G>A	p.Gly724Ser	missense_variant	Uncertain_significance		Neoplasm_of_the_large_intestine|EGFR-related_lung_cancer|not_specified	12	0.0
1	EGFR(0.0%)	exon19,c.2239_2256del,p.L747_S752del	0.0001646	0.0005879	9291|1	2341|1	0.00000	23014|0	7	55242468	55242486	ATTAAGAGAAGCAACATCT	A	base_qual,clustered_events,contamination,position,weak_evidence	EGFR	NM_005228.5	19	c.2239_2256del	p.Leu747_Ser752del	conservative_inframe_deletion	drug_response		Tyrosine_kinase_inhibitor_response	0	0.0
1	EGFR(0.1%)	exon20,c.2369C>T,p.T790M	0.0007472	0.0009543	4773|3	1397|0	0.00061	9818|6	7	55249071	55249071	C	T	clustered_events,contamination,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2369C>T	p.Thr790Met	missense_variant	drug_response		Non-small_cell_lung_carcinoma|Lung_carcinoma|Lung_cancer|Hereditary_cancer-predisposing_syndrome|Nonsmall_cell_lung_cancer,_resistance_to_tyrosine_kinase_inhibitor_in|EGFR-related_lung_cancer|Tyrosine_kinase_inhibitor_response|erlotinib_response_-_Efficacy|gefitinib_response_-_Efficacy|not_provided	29	0.0
1	EGFR(0.1%)	exon20,c.2374C>T,p.L792F	0.0008331	0.0009561	4764|4	1391|0	0.00069	10167|7	7	55249076	55249076	C	T	clustered_events,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2374C>T	p.Leu792Phe	missense_variant	Uncertain_significance		EGFR-related_lung_cancer	39	0.0
1	EGFR(0.1%)	exon20,c.2375T>A,p.L792H	0.0006301	0.0009681	4735|5	1378|1	0.00258	10071|26	7	55249077	55249077	T	A	base_qual,clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2375T>A	p.Leu792His	missense_variant				28	0.0
1	EGFR(0.0%)	exon20,c.2386G>C,p.G796R	0.0003204	0.0009885	4653|3	1343|2	0.00259	9246|24	7	55249088	55249088	G	C	clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2386G>C	p.Gly796Arg	missense_variant				47	0.0
1	EGFR(0.1%)	exon20,c.2387G>A,p.G796D	0.0007641	0.001967	4614|5	1333|2	0.00082	9722|8	7	55249089	55249089	G	A	clustered_events,normal_artifact,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2387G>A	p.Gly796Asp	missense_variant	Uncertain_significance		EGFR-related_lung_cancer	49	0.0
1	EGFR(0.0%)	exon20,c.2389T>A,p.C797S	0.0003273	0.001015	4527|11	1292|4	0.00420	9475|40	7	55249091	55249091	T	A	base_qual,clustered_events,orientation,weak_evidence	EGFR	NM_005228.5	20	c.2389T>A	p.Cys797Ser	missense_variant	not_provided		Non-small_cell_lung_carcinoma	32	0.0
1	EGFR(0.0%)	exon20,c.2389T>G,p.C797G	0.0003249	0.001044	4527|9	1292|10	0.00337	9475|32	7	55249091	55249091	T	G	base_qual,clustered_events,orientation,weak_evidence	EGFR	NM_005228.5	20	c.2389T>G	p.Cys797Gly	missense_variant				26	0.0
1	EGFR(0.0%)	exon21,c.2500G>C,p.V834L	0.0003317	0.001389	4325|3	972|0	0.00157	8929|14	7	55259442	55259442	G	C	base_qual,clustered_events,strand_bias,weak_evidence	EGFR	NM_005228.5	21	c.2500G>C	p.Val834Leu	missense_variant	Uncertain_significance		not_specified	59	0.0
1	EGFR(0.1%)	exon21,c.2572C>A,p.L858M	0.0005678	0.001527	3972|4	876|0	0.00167	8359|14	7	55259514	55259514	C	A	base_qual,clustered_events,strand_bias,weak_evidence	EGFR	NM_005228.5	21	c.2572C>A	p.Leu858Met	missense_variant	Uncertain_significance		Non-small_cell_lung_carcinoma|not_specified	51	0.0
1	EGFR(0.0%)	exon21,c.2573T>G,p.L858R	0.0003733	0.001572	3938|5	859|1	0.00229	8270|19	7	55259515	55259515	T	G	base_qual,clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	21	c.2573T>G	p.Leu858Arg	missense_variant	drug_response		Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Lung_carcinoma|Adenocarcinoma_of_lung,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Nonsmall_cell_lung_cancer,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Erlotinib_response|Gefitinib_response|Tyrosine_kinase_inhibitor_response|gefitinib_response_-_Efficacy	36	0.0
1	EGFR(0.1%)	exon21,c.2582T>A,p.L861Q	0.0006338	0.001628	3757|4	808|2	0.00354	7875|28	7	55259524	55259524	T	A	base_qual,clustered_events,orientation,weak_evidence	EGFR	NM_005228.5	21	c.2582T>A	p.Leu861Gln	missense_variant	Pathogenic/Likely_pathogenic|_drug_response		Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Tyrosine_kinase_inhibitor_response	25	0.0
1	MET(0.0%)	exon14,c.2888-1G>A	0.0004296	0.0006839	9290|4	3473|2	0.00059	45647|27	7	116411902	116411902	G	A	strand_bias,weak_evidence	MET	NM_000245.4	13	c.2888-1G>A		splice_acceptor_variant&intron_variant				20	0.0
1	MET(0.0%)	exon14,c.3007T>A,p.Y1003N	0.0001576	0.0004882	9465|11	4349|4	0.00269	59596|161	7	116412022	116412022	T	A	base_qual,clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3007T>A	p.Tyr1003Asn	missense_variant				40	0.0
1	MET(0.0%)	exon14,c.3008A>T,p.Y1003F	0.0002282	0.0003487	9554|8	4377|12	0.00367	60060|221	7	116412023	116412023	A	T	clustered_events,weak_evidence	MET	NM_000245.4	14	c.3008A>T	p.Tyr1003Phe	missense_variant				46	0.0
1	MET(0.0%)	exon14,c.3028G>C,p.D1010H	0.0001495	0.000307	9667|6	4441|3	0.00124	60643|75	7	116412043	116412043	G	C	clustered_events,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028G>C	p.Asp1010His	missense_variant&splice_region_variant				29	0.0
1	MET(0.0%)	exon14,c.3028G>T,p.D1010Y	0.0001498	0.0003099	9667|9	4441|10	0.00546	60643|333	7	116412043	116412043	G	T	clustered_events,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028G>T	p.Asp1010Tyr	missense_variant&splice_region_variant				35	0.0
1	MET(0.1%)	exon14,c.3028+1G>A	0.0006465	0.0003051	9671|6	4460|1	0.00115	60844|70	7	116412044	116412044	G	A	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028+1G>A		splice_donor_variant&intron_variant	not_provided		not_provided	38	0.0
1	MET(0.0%)	exon14,c.3028+2T>A	0.0003455	0.0003135	9585|12	4421|8	0.00325	60360|197	7	116412045	116412045	T	A	clustered_events,orientation,weak_evidence	MET	NM_000245.4	14	c.3028+2T>A		splice_donor_variant&intron_variant				26	0.0
1	MET(0.0%)	exon14,c.3028+2T>C	0.0003474	0.0003068	9585|3	4421|0	0.00050	60360|30	7	116412045	116412045	T	C	clustered_events,orientation,weak_evidence	MET	NM_000245.4	14	c.3028+2T>C		splice_donor_variant&intron_variant	not_provided		not_provided	30	0.0
	BRAF(0.0%)	exon15,c.1802A>T,p.K601I	0.0001943	0.0005927	7599|13	2341|10	0.00586	31568|186	7	140453133	140453133	T	A	clustered_events,weak_evidence,low_allele_frac	BRAF	NM_004333.6	15	c.1802A>T	p.Lys601Ile	missense_variant	Pathogenic		Cardiofaciocutaneous_syndrome_1|Cardio-facio-cutaneous_syndrome|Rasopathy|not_provided	42	0.0
	BRAF(0.0%)	exon15,c.1799T>C,p.V600A	0.000487	0.0005807	7539|4	2304|0	0.00055	31036|17	7	140453136	140453137	A	G	clustered_events,orientation,strand_bias,weak_evidence,low_allele_frac	BRAF	NM_004333.6	15	c.1799T>C	p.Val600Ala	missense_variant	Likely_pathogenic		Melanoma	43	0.0
1	BRAF(0.0%)	exon15,c.1799T>A,p.V600E	0.0001908	0.0005933	7539|5	2304|7	0.00487	31036|152	7	140453136	140453137	A	T	clustered_events,orientation,strand_bias,weak_evidence	BRAF	NM_004333.6	15	c.1799T>A	p.Val600Glu	missense_variant	Pathogenic|_drug_response|_other		Cystic_epithelial_invagination_containing_papillae_lined_by_columnar_epithelium|See_cases|Trametinib-Dabrafenib_Response|Vemurafenib-Cobimetinib_Response|Nephroblastoma|Cerebral_arteriovenous_malformation|Neoplasm|Melanoma|Papillary_thyroid_carcinoma|Multiple_myeloma|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Neoplasm_of_brain|Colonic_neoplasm|Neoplasm_of_ovary|Gastrointestinal_stroma_tumor|Lymphangioma|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Malignant_neoplastic_disease|Lung_carcinoma|Malignant_Colorectal_Neoplasm|Squamous_cell_carcinoma_of_the_head_and_neck|Cardio-facio-cutaneous_syndrome|Glioblastoma|Germ_cell_tumor,_nonseminomatous|Papillary_renal_cell_carcinoma,_sporadic|Astrocytoma,_low-grade,_somatic|not_provided	28	0.0
1	BRAF(0.1%)	exon15,c.1798G>A,p.V600M	0.0006987	0.001046	7547|5	2313|1	0.00061	31286|19	7	140453137	140453137	C	T	clustered_events,orientation,weak_evidence	BRAF	NM_004333.6	15	c.1798G>A	p.Val600Met	missense_variant	Likely_pathogenic		Melanoma|Non-small_cell_lung_carcinoma|not_provided	29	0.0
	BRAF(0.1%)	exon15,c.1796C>T,p.T599I	0.001253	0.001168	7464|11	2288|2	0.00135	30975|42	7	140453139	140453139	G	A	clustered_events,orientation,weak_evidence,low_allele_frac	BRAF	NM_004333.6	15	c.1796C>T	p.Thr599Ile	missense_variant	Pathogenic		Neoplasm|Melanoma|Cardiofaciocutaneous_syndrome_1|Noonan_syndrome|Rasopathy|not_provided	38	0.0
-	KMT2C(2.5%)	exon38,c.8390dup,p.E2798fs	0.025	0.029	8051|267	3443|132	0.04115	39822|1709	7	151874147	151874148	CT	CTT	multiallelic,normal_artifact,slippage,suspected_bg	KMT2C	NM_170606.3	38	c.8390dup	p.Glu2798fs	frameshift_variant	Pathogenic		not_provided	40	0.0
	KMT2C(7.7%)	exon16,c.2763A>G,p.L921=	0.077	0.084	80|6	13|0	0.07477	99|8	7	151932908	151932908	T	C	clustered_events,contamination,haplotype,background	KMT2C	NM_170606.3	16	c.2763A>G	p.Leu921=	synonymous_variant				25	0.0
	KMT2C(6.0%)	exon16,c.2755G>C,p.V919L	0.06	0.083	84|3	13|0	0.03774	102|4	7	151932916	151932916	C	G	clustered_events,contamination,haplotype,background	KMT2C	NM_170606.3	16	c.2755G>C	p.Val919Leu	missense_variant				32	0.0
	RET(0.0%)	exon11,c.1900T>A,p.C634S	0.0002618	0.0006804	5317|4	1635|0	0.00429	22025|95	10	43609948	43609948	T	A	clustered_events,strand_bias,weak_evidence,low_allele_frac	RET	NM_020975.6	11	c.1900T>A	p.Cys634Ser	missense_variant	Pathogenic		Multiple_endocrine_neoplasia,_type_2	48	0.0
1	RET(0.1%)	exon11,c.1900T>C,p.C634R	0.0008348	0.0006858	5317|7	1635|2	0.00041	22025|9	10	43609948	43609948	T	C	clustered_events,strand_bias,weak_evidence	RET	NM_020975.6	11	c.1900T>C	p.Cys634Arg	missense_variant	Pathogenic		Pheochromocytoma|Medullary_thyroid_carcinoma|Thyroid_carcinoma|Multiple_endocrine_neoplasia,_type_1|Multiple_endocrine_neoplasia,_type_2b|Multiple_endocrine_neoplasia,_type_2a|Multiple_endocrine_neoplasia,_type_4|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia,_type_2|not_provided	44	0.0
	FGFR2(0.4%)	exon7,c.903C>T,p.Y301=	0.004029	0.002754	3390|12	812|2	0.00381	6276|24	10	123279529	123279529	G	A	low_allele_frac	FGFR2	NM_000141.5	7	c.903C>T	p.Tyr301=	synonymous_variant				33	0.0
	IFITM3(2.3%)	exon1,c.124A>T,p.T42S	0.023	0.025	372|8	49|0	0.06259	659|44	11	320690	320690	T	A	clustered_events,contamination,orientation,background	IFITM3	NM_021034.3	1	c.124A>T	p.Thr42Ser	missense_variant				24	0.0
	CCND1(0.4%)	exon2,c.391T>A,p.S131T	0.004097	0.003002	2273|13	486|1	0.00822	4586|38	11	69457991	69457991	T	A	background,low_allele_frac	CCND1	NM_053056.3	2	c.391T>A	p.Ser131Thr	missense_variant				40	0.0
-	ATM(29.9%)	exon6,c.497-4del	0.299	0.427	76|40	7|7	0.23944	216|68	11	108114661	108114662	AT	A	germline,multiallelic,normal_artifact,suspected_bg	ATM	NM_000051.4	5	c.497-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_specified|not_provided	48	0.0
-	ATM(7.9%)	exon6,c.497-4dup	0.079	0.151	76|9	7|3	0.10373	216|25	11	108114661	108114662	AT	ATT	germline,multiallelic,normal_artifact,suspected_bg	ATM	NM_000051.4	5	c.497-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Ataxia-telangiectasia_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	39	0.0
	CD3G(6.6%)	exon3,c.213del,p.K71fs	0.066	0.051	2761|219	702|44	0.06866	6158|454	11	118220582	118220583	TA	T	multiallelic,normal_artifact,slippage,suspected_bg	CD3G	NM_000073.3	3	c.213del	p.Lys71fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|_Uncertain_significance(1)	Immunodeficiency_17	45	0.0
	CD3G(2.1%)	exon3,c.213dup,p.W72fs	0.021	0.022	2761|81	702|18	0.02702	6158|171	11	118220582	118220583	TA	TAA	multiallelic,normal_artifact,slippage,suspected_bg	CD3G	NM_000073.3	3	c.213dup	p.Trp72fs	frameshift_variant	Pathogenic		Immunodeficiency_17	40	0.0
	CBL(28.0%)	exon14,c.2173C>A,p.Q725K	0.28	0.006308	738|284	209|0	0.27709	1054|404	11	119168113	119168113	C	A	PASS	CBL	NM_005188.4	14	c.2173C>A	p.Gln725Lys	missense_variant				39	0.0
1	KRAS(0.1%)	exon4,c.436G>T,p.A146S	0.0006423	0.0006834	5769|4	3597|5	0.00259	29285|76	12	25378562	25378562	C	A	strand_bias,weak_evidence	KRAS	NM_033360.4	4	c.436G>T	p.Ala146Ser	missense_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1)|_Uncertain_significance(1)	Rasopathy|not_provided	12	0.0
1	KRAS(0.1%)	exon4,c.436G>A,p.A146T	0.0008984	0.0003795	5769|5	3597|0	0.00204	29285|60	12	25378562	25378562	C	T	strand_bias,weak_evidence	KRAS	NM_033360.4	4	c.436G>A	p.Ala146Thr	missense_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1)|_Uncertain_significance(1)	OCULOECTODERMAL_SYNDROME,_SOMATIC|Neoplasm_of_the_large_intestine|Encephalocraniocutaneous_lipomatosis|Rasopathy|not_provided	37	0.0
1	KRAS(0.0%)	exon3,c.182A>T,p.Q61L	0.0003562	0.0006217	6144|7	3656|4	0.00320	32687|105	12	25380276	25380277	T	A	base_qual,clustered_events,weak_evidence	KRAS	NM_033360.4	3	c.182A>T	p.Gln61Leu	missense_variant	Pathogenic		Medullary_thyroid_carcinoma|Multiple_myeloma|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine	42	0.0
1	KRAS(0.1%)	exon3,c.181C>A,p.Q61K	0.0005001	0.0003912	6136|3	3656|3	0.00164	32874|54	12	25380277	25380277	G	T	base_qual,clustered_events,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	3	c.181C>A	p.Gln61Lys	missense_variant	Pathogenic		Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine	23	0.0
1	KRAS(0.3%)	exon3,c.175G>A,p.A59T	0.002715	0.00163	5880|15	3504|5	0.00201	31341|63	12	25380283	25380283	C	T	clustered_events,normal_artifact	KRAS	NM_033360.4	3	c.175G>A	p.Ala59Thr	missense_variant	Pathogenic/Likely_pathogenic		Neoplasm_of_the_large_intestine|Bladder_cancer,_transitional_cell,_somatic	32	0.0
1	KRAS(0.1%)	exon2,c.38G>A,p.G13D	0.0005122	0.0003318	6793|3	3964|0	0.00115	31313|36	12	25398281	25398282	C	T	clustered_events,orientation,weak_evidence	KRAS	NM_033360.4	2	c.38G>A	p.Gly13Asp	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(5)|_Uncertain_significance(1)	OCULOECTODERMAL_SYNDROME,_SOMATIC|Acute_myeloid_leukemia|Nevus_sebaceous|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Breast_adenocarcinoma|Encephalocraniocutaneous_lipomatosis|RAS-associated_autoimmune_leukoproliferative_disorder|Noonan_syndrome_and_Noonan-related_syndrome|Rasopathy|Inborn_genetic_diseases|not_provided	66	0.0
1	KRAS(0.0%)	exon2,c.37G>T,p.G13C	0.0003157	0.0003397	6789|3	3961|5	0.00218	31571|69	12	25398282	25398282	C	A	clustered_events,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	2	c.37G>T	p.Gly13Cys	missense_variant	Pathogenic		Non-small_cell_lung_carcinoma|Neoplasm_of_the_large_intestine|RAS-associated_autoimmune_leukoproliferative_disorder|not_provided	24	0.0
1	KRAS(0.0%)	exon2,c.37G>C,p.G13R	0.0004161	0.0003341	6789|3	3961|0	0.00085	31571|27	12	25398282	25398282	C	G	clustered_events,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	2	c.37G>C	p.Gly13Arg	missense_variant	Pathogenic		Non-small_cell_lung_carcinoma|Pilocytic_astrocytoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine|not_provided	10	0.0
1	KRAS(0.1%)	exon2,c.37G>A,p.G13S	0.000795	0.00051	6789|7	3961|1	0.00066	31571|21	12	25398282	25398282	C	T	clustered_events,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	2	c.37G>A	p.Gly13Ser	missense_variant	Pathogenic		Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine	55	0.0
1	KRAS(0.0%)	exon2,c.35G>A,p.G12D	0.0003952	0.0003329	6786|3	3954|0	0.00057	31331|18	12	25398284	25398285	C	T	clustered_events,orientation,weak_evidence	KRAS	NM_033360.4	2	c.35G>A	p.Gly12Asp	missense_variant	Pathogenic		Vascular_Tumors_Including_Pyogenic_Granuloma|Acute_myeloid_leukemia|Cerebral_arteriovenous_malformation|Neoplasm_of_stomach|Nevus_sebaceous|Epidermal_nevus|Linear_sebaceous_nevus_sequence|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Lung_carcinoma|Carcinoma_of_pancreas|Encephalocraniocutaneous_lipomatosis|RAS-associated_autoimmune_leukoproliferative_disorder|Capillary_malformation-arteriovenous_malformation_1|Rasopathy|Primary_low_grade_serous_adenocarcinoma_of_ovary|not_provided	56	0.0
1	KRAS(0.1%)	exon2,c.34G>T,p.G12C	0.0007808	0.0003369	6793|6	3953|6	0.00285	31542|90	12	25398285	25398285	C	A	clustered_events,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	2	c.34G>T	p.Gly12Cys	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(7)|_Likely_pathogenic(1)|_Uncertain_significance(1)	Endometrial_carcinoma|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Lung_carcinoma|Gallbladder_cancer|not_provided	48	0.0
1	KRAS(0.1%)	exon2,c.34G>A,p.G12S	0.0007716	0.0007192	6793|5	3953|2	0.00095	31542|30	12	25398285	25398285	C	T	clustered_events,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	2	c.34G>A	p.Gly12Ser	missense_variant	Pathogenic		Stomach_cancer|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Rasopathy|not_provided	48	0.0
	KMT2D(3.9%)	exon11,c.2509T>G,p.S837A	0.039	0.061	919|108	145|35	0.00747	664|5	12	49444957	49445038	ACTGGGGGGACAGGTGTGATTCCTCAGGTTGGGGGGACAAGCATGGCTCCTCAGGCACAGGAGACAGGTGCGGCTCCTCAGT	CCTGGGGGGACAGGTGTGATTCCTCAGGTTGGGGGGACAAGCATGGCTCCTCAGGCACAGGAGACAGGTGCGGCTCCTCAGT	clustered_events,multiallelic,background	KMT2D	NM_003482.4	11	c.2509T>G	p.Ser837Ala	missense_variant				19	0.0
-	HNF1A(3.0%)	exon4,c.872dup,p.G292fs	0.03	0.032	314|13	63|1	0.03565	568|21	12	121432117	121432117	G	GC	contamination,normal_artifact,slippage,weak_evidence	HNF1A	NM_000545.8	4	c.872dup	p.Gly292fs	frameshift_variant	Pathogenic		Maturity_onset_diabetes_mellitus_in_young|Clear_cell_carcinoma_of_kidney|Diabetes_mellitus_type_1|Hepatic_adenomas,_familial|Maturity-onset_diabetes_of_the_young,_type_3|Diabetes_mellitus,_insulin-dependent,_20|not_provided	41	0.0
-	BRCA2(0.7%)	exon10,c.1813dup,p.I605fs	0.006686	0.015	2791|29	457|8	0.00813	5614|46	13	32907420	32907420	G	GA	contamination,normal_artifact,slippage,weak_evidence,suspected_bg,low_allele_frac	BRCA2	NM_000059.4	10	c.1813dup	p.Ile605fs	frameshift_variant	Pathogenic		Carcinoma_of_breast|Hereditary_breast_and_ovarian_cancer_syndrome|Carcinoma_of_pancreas|Breast-ovarian_cancer,_familial_1|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Breast_and/or_ovarian_cancer|BRCA2-Related_Disorders|not_provided	28	0.0
-	BRCA2(3.0%)	exon23,c.9097dup,p.T3033fs	0.03	0.031	2069|72	418|13	0.03395	3813|134	13	32954022	32954022	C	CA	normal_artifact,slippage,distinguished	BRCA2	NM_000059.4	23	c.9097dup	p.Thr3033fs	frameshift_variant	Pathogenic		Carcinoma_of_breast|Neoplasm_of_ovary|Hereditary_breast_and_ovarian_cancer_syndrome|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial_1|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Breast_and/or_ovarian_cancer|not_provided	40	0.0
	NBEA(0.9%)	exon22,c.3362dup,p.N1121fs	0.008617	0.012	5957|96	1320|28	0.01638	16576|276	13	35733662	35733663	TA	TAA	multiallelic,normal_artifact,slippage,suspected_bg	NBEA	NM_015678.5	22	c.3362dup	p.Asn1121fs	frameshift_variant	Likely_pathogenic		Neurodevelopmental_disorder_with_or_without_early-onset_generalized_epilepsy	42	0.0
-	RB1(2.0%)	exon7,c.608-4dup	0.02	0.038	4878|139	2012|97	0.04341	25605|1162	13	48934140	48934140	A	AT	contamination,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	6	c.608-4dup		splice_region_variant&intron_variant	Benign		Retinoblastoma	37	0.0
	AKT1(4.4%)	exon5,c.349_351del,p.E117del	0.044	0.028	181|7	41|0	0.03361	230|8	14	105242072	105242075	TCTC	T	contamination,slippage,distinguished	AKT1	NM_005163.2	5	c.349_351del	p.Glu117del	conservative_inframe_deletion	Uncertain_significance		Cowden_syndrome_6	47	0.0
	BLM(1.8%)	exon7,c.1544dup,p.N515fs	0.018	0.024	7081|178	3089|96	0.03348	34033|1179	15	91304138	91304138	G	GA	multiallelic,normal_artifact,suspected_bg	BLM	NM_000057.4	7	c.1544dup	p.Asn515fs	frameshift_variant	Pathogenic/Likely_pathogenic		Hereditary_breast_and_ovarian_cancer_syndrome|Bloom_syndrome|Hereditary_cancer-predisposing_syndrome	39	0.0
	CHD2(7.8%)	exon29,c.3734del,p.K1245fs	0.078	0.037	509|57	141|6	0.06961	842|63	15	93540315	93540316	GA	G	multiallelic,normal_artifact,slippage,suspected_bg	CHD2	NM_001271.4	29	c.3734del	p.Lys1245fs	frameshift_variant&splice_region_variant	Pathogenic/Likely_pathogenic		Developmental_and_epileptic_encephalopathy_94|History_of_neurodevelopmental_disorder|not_provided	49	0.0
	CHD2(4.3%)	exon29,c.3734dup	0.043	0.082	509|35	141|15	0.06755	842|61	15	93540315	93540316	GA	GAA	multiallelic,normal_artifact,slippage,suspected_bg	CHD2	NM_001271.4	29	c.3734dup		splice_donor_variant&intron_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|_Likely_benign(1)	Developmental_and_epileptic_encephalopathy_94	41	0.0
	CHD2(4.7%)	exon33,c.4173dup,p.Q1392fs	0.047	0.067	225|11	54|3	0.03662	342|13	15	93545433	93545433	G	GA	normal_artifact,slippage,suspected_bg	CHD2	NM_001271.4	33	c.4173dup	p.Gln1392fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(4)|_Uncertain_significance(1)	CHD2-Related_Disorder|Autistic_behavior|Seizure|Developmental_and_epileptic_encephalopathy_94|Complex_neurodevelopmental_disorder|not_provided	39	0.0
-	CREBBP(2.4%)	exon16,c.3250del,p.I1084fs	0.024	0.026	602|16	55|1	0.02259	822|19	16	3817720	3817721	CT	C	contamination,suspected_bg	CREBBP	NM_004380.3	16	c.3250del	p.Ile1084fs	frameshift_variant&splice_region_variant				33	0.0
-	CDH1(0.5%)	exon3,c.259del,p.R87fs	0.005474	0.003624	9530|80	3248|19	0.00532	42216|226	16	68835664	68835665	CA	C	normal_artifact,low_allele_frac	CDH1	NM_004360.5	3	c.259del	p.Arg87fs	frameshift_variant	Pathogenic		Hereditary_diffuse_gastric_cancer	45	0.0
	TP53(23.7%)	exon5,c.527G>A,p.C176Y	0.237	0.002383	3851|1240	1447|3	0.23464	9619|2949	17	7578403	7578403	C	T	PASS	TP53	NM_000546.6	5	c.527G>A	p.Cys176Tyr	missense_variant	Pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Lung_adenocarcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Adenocarcinoma_of_prostate|Ovarian_Serous_Cystadenocarcinoma|Squamous_cell_carcinoma_of_the_head_and_neck|Hereditary_cancer-predisposing_syndrome|Familial_ovarian_cancer|Li-Fraumeni_syndrome|not_provided	35	0.0
	FLCN(17.0%)	exon11,c.1285del,p.H429fs	0.17	0.107	37|7	10|0	0.10345	52|6	17	17119708	17119709	TG	T	base_qual,slippage	FLCN	NM_144997.7	11	c.1285del	p.His429fs	frameshift_variant	Pathogenic		Multiple_fibrofolliculomas|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	17	0.0
-	NF1(3.8%)	exon2,c.61-4del	0.038	0.025	548|31	90|1	0.03882	916|37	17	29482988	29482989	CT	C	normal_artifact,slippage,suspected_bg	NF1	NM_000267.3	1	c.61-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Neurofibromatosis,_familial_spinal|Caf??-au-lait_macules_with_pulmonary_stenosis|Neurofibromatosis-Noonan_syndrome|Neurofibromatosis,_type_1|not_specified|not_provided	39	0.0
-	NF1(1.7%)	exon18,c.2033del,p.P678fs	0.017	0.018	2545|52	411|9	0.01623	5335|88	17	29553477	29553478	AC	A	contamination,normal_artifact,background	NF1	NM_000267.3	18	c.2033del	p.Pro678fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome|Neurofibromatosis,_type_1|not_provided	38	0.0
	KRTAP4-11(8.8%)	exon1,c.294T>C,p.T98=	0.088	0.044	161|20	17|0	0.41250	376|264	17	39274274	39274274	A	G	haplotype,background	KRTAP4-11	NM_033059.4	1	c.294T>C	p.Thr98=	synonymous_variant				14	0.0
-	SMAD4(25.7%)	exon11,c.1447+2dup	0.257	0.001201	2388|840	1068|0	0.22775	5822|1717	18	48603147	48603147	G	GT	PASS	SMAD4	NM_005359.6	11	c.1447+2dup		splice_region_variant&intron_variant				48	0.0
	POLR1G(0.4%)	exon3,c.1510del,p.Q504fs	0.004048	0.002984	2437|9	423|0	0.00000	1559|0	19	45912735	45912736	GC	G	low_allele_frac	POLR1G	NM_012099.3	3	c.1510del	p.Gln504fs	frameshift_variant				26	0.0
	BICRA(2.3%)	exon8,c.2786T>G,p.V929G	0.023	0.013	699|39	89|3	0.12832	1542|227	19	48197874	48197874	T	G	orientation,background	BICRA	NM_015711.3	8	c.2786T>G	p.Val929Gly	missense_variant				36	0.0
	BAX(3.4%)	exon3,c.121del,p.E41fs	0.034	0.025	2827|124	503|18	0.03448	6916|247	19	49458970	49458971	TG	T	multiallelic,normal_artifact,slippage,suspected_bg	BAX	NM_138761.4	3	c.121del	p.Glu41fs	frameshift_variant	Pathogenic		Carcinoma_of_colon	46	0.0
	NEFH(6.6%)	exon4,c.1965_2015delinsTGAGAAGGCCAAGTCCCCAGAGAAGGA,p.E658_A672>AKSPEKE	0.066	0.047	124|8	23|0	0.00000	43|0	22	29885594	29885644	AGAGAAGGAAGAGGCCAAGTCCCCTGAGAAGGCCAAGTCCCCAGTGAAGGC	TGAGAAGGCCAAGTCCCCAGAGAAGGA	clustered_events,contamination,haplotype	NEFH	NM_021076.4	4	c.1965_2015delinsTGAGAAGGCCAAGTCCCCAGAGAAGGA	p.Glu658_Ala672delinsAlaLysSerProGluLysGlu	missense_variant&disruptive_inframe_deletion	Benign/Likely_benign		Inborn_genetic_diseases|not_provided	34	0.0
	KDM6A(42.7%)	exon23,c.3319C>A,p.P1107T	0.427	0.025	174|134	51|0	0.44651	238|192	X	44942739	44942739	C	A	PASS	KDM6A	NM_021140.4	23	c.3319C>A	p.Pro1107Thr	missense_variant				40	0.0
	MED12(8.3%)	exon42,c.6165_6167del,p.Q2056del	0.083	0.072	81|7	10|0	0.04444	172|8	X	70360588	70360591	GAGC	G	contamination,slippage,distinguished	MED12	NM_005120.3	42	c.6165_6167del	p.Gln2056del	disruptive_inframe_deletion	Uncertain_significance		FG_syndrome_1	42	0.0
